Published in Int J Colorectal Dis on January 01, 1989
Endoscopic Nd:YAG laser treatment of rectosigmoid cancer. Gut (1990) 0.83
Ablative therapies for colorectal polyps and malignancy. Biomed Res Int (2014) 0.76
General surgery. Postgrad Med J (1990) 0.75
Radiation enhancement of laser palliation for advanced rectal and rectosigmoid cancer: a pilot study. Gut (1993) 0.75
Palliative treatment of rectosigmoid carcinoma by laser endoscopic photoablation. Gastroenterology (1987) 1.27
[Treatment of rectal cancer with the neodymium-YAG laser]. Gastroenterol Clin Biol (1986) 1.14
Laser irradiation of inoperable tumours of the colon and rectum. Br Med J (Clin Res Ed) (1985) 1.13
Endoscopic treatment of inoperable colorectal cancers with the Nd YAG laser. Br J Surg (1986) 1.12
Preoperative neodymium-YAG laser treatment of obstructive colon cancer. Endoscopy (1986) 0.91
[Palliative treatment of adenocarcinoma of the rectum by Nd-YAG laser. Immediate and long-term results. Study of factors related to the initial destruction of the tumor]. Gastroenterol Clin Biol (1986) 0.89
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet (1997) 6.71
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Predictability of the postoperative course of Crohn's disease. Gastroenterology (1990) 5.30
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet (1991) 5.02
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut (2008) 4.41
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut (2007) 4.21
Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology (1993) 4.14
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology (1998) 4.08
The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest (1977) 3.89
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut (2006) 3.57
Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy. Gut (2009) 3.50
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology (1995) 3.44
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut (2008) 3.14
Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med (1998) 3.13
Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut (2006) 3.00
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology (2001) 2.81
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology (1999) 2.80
Yersinia enteritis and enterocolitis: gastroenterological aspects. Gastroenterology (1977) 2.79
Non-alcoholic duct destructive chronic pancreatitis. Gut (1997) 2.79
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol (2000) 2.77
Ankylosing spondylitis: an overview. Ann Rheum Dis (2002) 2.71
Appendectomy protects against ulcerative colitis. Gastroenterology (1994) 2.71
Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut (1984) 2.70
Treatment of achalasia and related motor disorders. Gastroenterology (1980) 2.68
Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med (1990) 2.67
Microscopic colitis with giant cells. Histopathology (2002) 2.64
Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology (1999) 2.46
Current status of genetics research in inflammatory bowel disease. Genes Immun (2005) 2.29
Treatment of achalasia with pneumatic dilatations. Gut (1971) 2.26
Endoscopic injection therapy to prevent rebleeding from peptic ulcers with a protruding vessel: a controlled comparative trial. Gut (1993) 2.25
Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis. Aliment Pharmacol Ther (2015) 2.25
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 2.23
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21
Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut (2009) 2.20
Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology (1997) 2.18
To dilate or to operate? That is the question. Gut (1983) 2.16
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis. Gut (2009) 2.08
Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology (1996) 2.08
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol (2001) 2.06
Erythromycin is a motilin receptor agonist. Am J Physiol (1989) 2.00
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99
Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer. Gut (1980) 1.95
Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease. Aliment Pharmacol Ther (2001) 1.94
Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Aliment Pharmacol Ther (2004) 1.87
Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology (1997) 1.84
24-hour recording of esophageal pressure and pH in patients with noncardiac chest pain. Gastroenterology (1986) 1.75
In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology (1998) 1.74
Achalasia, diffuse esophageal spasm, and related motility disorders. Gastroenterology (1979) 1.73
Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. Am J Gastroenterol (1997) 1.69
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology (1999) 1.68
Motilin and the interdigestive migrating motor complex in man. Dig Dis Sci (1979) 1.67
Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis (2003) 1.66
The irritable oesophagus--a frequent cause of angina-like pain. Lancet (1987) 1.65
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Smallest detectable difference in radiological progression. J Rheumatol (1999) 1.64
Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology (1992) 1.62
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther (2004) 1.62
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1998) 1.60
Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. Gastrointest Endosc (1999) 1.59
Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol (1989) 1.59
Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania. Ann Rheum Dis (2003) 1.58
Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials. Rheumatology (Oxford) (1999) 1.57
Comparison of total and compartmental gastric emptying and antral motility between healthy men and women. Eur J Nucl Med (1998) 1.56
Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut (1999) 1.55
Ambulatory gastrojejunal manometry in severe motility-like dyspepsia: lack of correlation between dysmotility, symptoms, and gastric emptying. Gut (1998) 1.54
European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis (2013) 1.53
Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology (1992) 1.53
The Paneth cell: a source of intestinal lysozyme. Gut (1975) 1.50
Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet (1990) 1.49